Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Hi-Tech Pharmaceuticals: Diosterol™ brand Dioscorea Nipponica Makino is a Precision Anabolic & Androgenic extract designed for hard-training athletes who want to get more out of their workout by Boosting Testosterone levels

      Hi-Tech Pharmaceuticals, Inc.

      News provided by

      Hi-Tech Nutraceuticals, LLC.

      Mar 30, 2015, 03:50 ET

      Share this article

      Share this article


      NORCROSS, Ga., March 30, 2015 /PRNewswire/ -- A new proprietary extract called Diosterol™ from Dioscorea Nipponica Makino has been released in the United States. Diosterol™ is a Precision Anabolic & Androgenic extract designed for hard-training athletes who want to get more out of their workout by boosting Testosterone levels. This potent plant anabolic is a concentrated (Drug to extract ratio: 5066.7:1) equal to 10 -13.4 grams of the whole plant. Diosterol™ is standardized to contain bioactive fractions rich in steroidal furostanolic saponins and glycosides: Progenin III, Pseudoprotodioscin, Methyl Protodioscin, Dioscin, Protodioscin, Iridoid Glycosides, Diosgenin and 5a-Hydroxy Laxogenin. Perhaps the most potent compound in this state-of-the-art extract is 5a-Hydroxy Laxogenin. 5a-Hydroxy Laxogenin is the plant-based steroid that can be extracted from Smilax sieboldii and certain Dioscorea species and can be synthesized from diosgenin. Due to the complicated purifying process to identify the active ingredients it takes 2000 lbs of raw Dioscorea to make just 40 lbs of Diosterol™!

      Diosterol™ has been clinically HPLC tested to be the strongest Dioscorea extract for boosting testosterone levels extract in the world with an average content of over 100 mg of protodioscin per suggested 250mg dose. The total Furostanol Saponins (active ingredients) with up to 60%.

      Hi-Tech Nutraceuticals, the fastest growing specialty raw material supplier in the sports nutrition industry, promised to bring its customers, distributors, and consumers lots of state-of-the-science ingredients this year. They live up to their word with the launch of Diosterol™, a proprietary extract meant to boost testosterone levels. The upcoming release of Diosterol™ represents a monumental addition to a product category that has been lacking in the industry—especially after the recent legislation that passed making most prohormones controlled substances like anabolic steroids. The release of Diosterol™ has Hi-Tech starting the year strong. As they move into the next quarter of 2015, Hi-Tech plans to continue to build upon the success and momentum.

      Quality: The herbal preparation is produced under GMP (Good Manufacturing Practice) conditions. Manufacturing practices were inspected and approved by 5 Fortune 500 companies and the factory has certification of GMP, HACCP, CNAS, HALAL, KOSHER and is now an official member of UNPA and a member in ISC. Control of the herbal preparation and suitable tests are performed to elucidate the structure and other characteristics of the herbal extract. Release specifications for the extract comprise of appearance, identification by TLC fingerprint, marker content, loss on drying, residual solvent, pesticides, heavy metals, aflatoxins and microbiological purity are tested in accordance with Ph. Eur.  Identity is tested in accordance with the monograph of the Chinese pharmacopoeia.

      Manufacture: The starting material is cultivated in the Henan Province of the People's Republic of China.  The cultivation of the plant and collection of the plant material are in accordance  with the guideline on Good Agricultural and Collection practice (EMEA/HMPC/24618/2005).

      Precursor for Testosterone Biosynthesis: Steroidal saponin-containing plant materials gained commercial significance in 1950s as raw materials for the production of steroid hormones and drugs. The synthesis of progesterone from the sapogenin diosgenin obtained from Mexican yam by Marker et al. in 1940s (Marker et al., 1947) was the beginning of a remarkable era in steroid research culminating in the synthesis of the first oral contraceptive in 1951. Diosgenin isolated from Dioscorea species and to a lesser extent structurally similar sapogenins have been widely used as raw materials by the steroid industry (Blunden et al., 1975).

      In China and Russia extracts of Dioscorea nipponica Makino have been on the market for more than 40 years.  Extracts of the roots of Dioscorea nipponica Makino have a long history of medicinal use in China. The herb was first recorded in 1959 and in 1977 a monograph of Dioscorea nipponica Makino was included in the official Chinese Pharmacopoeia. 5a-Hydroxy Laxogenin was discovered by an American scientist in 1996. It was shown to possess an anabolic/androgenic ratio similar to one of the most efficient anabolic substances. It was shown that 6-ketoderivatives of natural sapogenins display the anabolic activity and do not manifest any androgenic properties. Increased testosterone levels are known to increase muscle size and strength in men with downstream benefits on body weight, body fat, muscle size, strength, libido, energy, and mood. S. Bhasin, T.W. Storer, N. Berman, C. Callegari, B. Clevenger, J. Phillips, et al. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men N Engl J Med, 335 (1996), pp. 1–7

      Diosterol™ is the only science-based Dioscorea Nipponica Makino extract, standardized to a minimum of 40% Protodioscin, 60% Total furostanolic saponins, and 90% total saponins including Diosgenin and 5a-Hydroxy Laxogenin. Protodioscin acts by stimulating the enzyme 5-alpha-reductase, which plays a role in the conversion of testosterone into dihydrotestosterone (Viktorof et al. 1994). In addition, protodioscin also stimulates the hypothalamus secretion of luteinizing hormone (LH), but not of follicle stimulating hormone (FSH). The mechanism of protodioscin's action causes increases the production of serum testosterone

      Most of all, steroidal saponins have been identified as the bioactive constituents responsible for the anabolic and aphrodisiac effects, these saponins (of which protodioscin is the primary) enable the body to produce more testosterone by raising the levels of the Leuteinizing Hormone (LH), which a hormone released normally by the pituitary gland helps to maintain testosterone production. As the LH increases, so testosterone increases.  

      Diosterol™ is a Precision Anabolic & Androgenic extract designed for hard-training athletes who want to get more out of their workout by boosting Testosterone levels —  available only from Hi-Tech Nutraceuticals, LLC.—where science never stands still™!

      CONTACT: Brandon Schopp, 888-855-7919

      Logo - http://photos.prnewswire.com/prnh/20150330/195369LOGO

      SOURCE Hi-Tech Nutraceuticals, LLC.

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.